<?xml version="1.0" encoding="UTF-8"?>
<p>Similarly, 51 of the 100 samples neutralised one or more alphaviruses (
 <xref rid="T2" ref-type="table">Table 2</xref>). Of these, samples from 39 donors neutralised RRV and eight neutralised BFV to a greater extent than another; i.e., there was a significant difference between the reductions in plaque count (
 <italic>p</italic> &lt; 0.05). Only four samples neutralised both RRV and BFV.
</p>
